423.43MMarket Cap-5889P/E (TTM)
8.170High7.510Low149.41KVolume7.680Open7.730Pre Close1.19MTurnover0.57%Turnover RatioLossP/E (Static)52.86MShares9.09052wk High2.81P/B208.91MFloat Cap1.93052wk Low--Dividend TTM26.08MShs Float14.710Historical High--Div YieldTTM8.54%Amplitude1.450Historical Low7.933Avg Price1Lot Size
TScan Therapeutics Stock Forum
NEWS
TScan Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating TCR-T Therapy for the Treatment of Solid Tumors
NEWS
TScan Therapeutics Announces Closing of Upsized Public Offering
$Forza X1(FRZA.US)$
No comment yet